Alan H. Auerbach, President and CEO of Puma Biotechnology Inc. ($PBYI), made four open market sales of company shares over the past year, totaling about $372 thousand. His latest sale occurred on January 7, 2026. These transactions rank 7,112th out of 11,678 insiders in the database, well below the average sale value of $8.6 million across 6.4 transactions per insider. Auerbach recorded no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | A | Stock Option (Right to Buy) | 227474 | $0.00 | 227,474.0000 | 50,929,893 | 9999.99% | 0.45% |
| Feb. 18, 2026 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | A | Common Stock | 159778 | $0.00 | 7,305,729.0000 | 50,929,893 | 2.24% | 0.31% |
| Jan. 7, 2026 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | S | Common Stock | 18012 | $5.88 | 7,145,951.0000 | 50,929,893 | 0.25% | 0.04% |
| Jan. 6, 2026 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | S | Common Stock | 16938 | $5.84 | 7,163,963.0000 | 50,929,893 | 0.24% | 0.03% |
| July 8, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | S | Common Stock | 25592 | $3.53 | 7,202,481.0000 | 49,100,433 | 0.35% | 0.05% |
| July 9, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | S | Common Stock | 21580 | $3.54 | 7,180,901.0000 | 49,100,433 | 0.30% | 0.04% |
| Feb. 7, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | A | Common Stock | 198399 | $0.00 | 7,228,073.0000 | 49,100,433 | 2.82% | 0.40% |
| Feb. 7, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | A | Stock Option (Right to Buy) | 274622 | $0.00 | 274,622.0000 | 49,100,433 | 9999.99% | 0.56% |
| Jan. 2, 2025 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | S | Common Stock | 33841 | $3.15 | 7,029,674.0000 | 49,100,433 | 0.48% | 0.07% |
| July 17, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | S | Common Stock | 21920 | $3.70 | 7,063,515.0000 | 47,550,852 | 0.31% | 0.05% |
| July 2, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | S | Common Stock | 18885 | $3.27 | 7,085,435.0000 | 47,550,852 | 0.27% | 0.04% |
| March 15, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | A | Common Stock | 6577 | $0.00 | 7,104,320.0000 | 47,550,852 | 0.09% | 0.01% |
| March 15, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | A | Stock Option (Right to Buy) | 9047 | $0.00 | 9,047.0000 | 47,550,852 | 9999.99% | 0.02% |
| Feb. 12, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | A | Stock Option (Right to Buy) | 222573 | $0.00 | 222,573.0000 | 47,550,852 | 9999.99% | 0.47% |
| Feb. 12, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | A | Common Stock | 160796 | $0.00 | 7,097,743.0000 | 47,550,852 | 2.32% | 0.34% |
| Jan. 3, 2024 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | S | Common Stock | 41396 | $4.49 | 6,936,947.0000 | 47,550,852 | 0.59% | 0.09% |
| July 3, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | S | Common Stock | 60698 | $3.31 | 6,978,343.0000 | 44,929,998 | 0.86% | 0.14% |
| Feb. 10, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | A | Stock Option (Right to Buy) | 258924 | $0.00 | 258,924.0000 | 44,929,998 | 9999.99% | 0.58% |
| Feb. 10, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | A | Common Stock | 186403 | $0.00 | 7,039,041.0000 | 44,929,998 | 2.72% | 0.41% |
| Jan. 3, 2023 | PUMA BIOTECHNOLOGY, INC. | $PBYI | AUERBACH ALAN H | President and CEO | S | Common Stock | 27241 | $4.18 | 6,852,638.0000 | 44,929,998 | 0.40% | 0.06% |